KeyCorp began coverage on shares of HealthEquity (NASDAQ:HQY – Get Rating) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The firm issued an overweight rating and a $85.00 price target on the stock.

HQY has been the subject of several other reports. SVB Leerink increased their price objective on HealthEquity from $67.00 to $76.00 and gave the company an outperform rating in a research report on Tuesday, June 7th. Wells Fargo & Company upped their target price on HealthEquity from $95.00 to $100.00 and gave the company an overweight rating in a research note on Tuesday, September 13th. Robert W. Baird upped their target price on HealthEquity from $47.00 to $67.00 and gave the company a neutral rating in a research note on Wednesday, September 7th. Barrington Research upped their target price on HealthEquity from $70.00 to $75.00 in a research note on Tuesday, June 7th. Finally, Raymond James increased their price objective on HealthEquity from $70.00 to $75.00 and gave the stock an outperform rating in a research note on Monday, September 12th. Two analysts have rated the stock with a sell rating, one has issued a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, HealthEquity presently has a consensus rating of Moderate Buy and a consensus target price of $75.36.

HealthEquity Price Performance

Shares of HQY opened at $71.36 on Thursday. The company has a market capitalization of $6.03 billion, a price-to-earnings ratio of -96.43, a P/E/G ratio of 4.25 and a beta of 0.90. HealthEquity has a fifty-two week low of $36.81 and a fifty-two week high of $73.29. The business's 50-day moving average is $62.01 and its 200-day moving average is $62.38.

Insider Activity

In related news, COO Edward Bloomberg sold 1,000 shares of the company's stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $57.63, for a total transaction of $57,630.00. Following the sale, the chief operating officer now owns 59,850 shares in the company, valued at approximately $3,449,155.50. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 2.80% of the company's stock.

Institutional Trading of HealthEquity

A number of institutional investors and hedge funds have recently modified their holdings of the business. Private Trust Co. NA purchased a new stake in HealthEquity in the second quarter worth $28,000. Pinebridge Investments L.P. purchased a new position in shares of HealthEquity in the fourth quarter valued at $31,000. Assetmark Inc. grew its position in shares of HealthEquity by 387.1% in the second quarter. Assetmark Inc. now owns 755 shares of the company's stock valued at $46,000 after purchasing an additional 600 shares in the last quarter. Signaturefd LLC grew its position in shares of HealthEquity by 44.3% in the first quarter. Signaturefd LLC now owns 954 shares of the company's stock valued at $64,000 after purchasing an additional 293 shares in the last quarter. Finally, Clearstead Advisors LLC purchased a new position in shares of HealthEquity in the first quarter valued at $65,000. 99.43% of the stock is owned by hedge funds and other institutional investors.

About HealthEquity

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Articles

• Get a free copy of the StockNews.com research report on HealthEquity (HQY)
• Kroger's is Your One-Stop Consumer Staples Stock
• Adobe Perfects the Art of the Faceplant for Investors
• Tax Credits are the Incentives in the Inflation Reduction Act
• Stock Market: 3 Islands Of Strength In A Sea Of Red
• 3 Banks Worth Considering For Q4

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.